PDB38 COST SAVINGS IN TYPE 2 DIABETES WITH INSULIN GLARGINE COMPARED TO INSULIN DETEMIR IN A BASAL SUPPORTED ORAL THERAPY (BOT) IN GERMANY
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75016-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)75016-6/fulltext
Title :
PDB38 COST SAVINGS IN TYPE 2 DIABETES WITH INSULIN GLARGINE COMPARED TO INSULIN DETEMIR IN A BASAL SUPPORTED ORAL THERAPY (BOT) IN GERMANY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75016-6&doi=10.1016/S1098-3015(10)75016-6
First page :
Section Title :
Open access? :
No
Section Order :
942